Scientific deep-dive

Ozempic and Birth Control: Does Semaglutide Affect the Pill? (2026)

Semaglutide (Ozempic, Wegovy) carries no labeled warning that birth control is less effective, unlike tirzepatide (Mounjaro). But vomiting can cut pill absorption, and pregnancy must be avoided. What to know in 2026.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
9 min read·5 citations

Short answer: semaglutide (Ozempic, Wegovy) does not appear to make oral birth control less effective, and unlike tirzepatide it carries no labeled warning telling you the pill may stop working or that you need a backup method.[1][2] That is the single most important thing to know — and it is the opposite of Mounjaro (tirzepatide), whose label does warn that oral contraceptives may be less effective and advises a backup or non-oral method during dose escalation.[3] A peer-reviewed pharmacology review found that tirzepatide measurably lowered oral-contraceptive blood levels while the GLP-1 receptor agonists studied — semaglutide among them — did not.[5] But there are still two real cautions for Ozempic users: if its gastrointestinal side effects make you vomit or have diarrhea, that can reduce how much of an oral pill you absorb; and because semaglutide may harm a developing fetus, pregnancy must be avoided on it — which is exactly why reliable contraception matters here. Ozempic is semaglutide; see our Ozempic drug page and the broader Ozempic side effects guide. This is general educational information, not medical advice — your prescriber manages your care.

About this article

The claims below about what each label does and does not say were verified against the FDA prescribing information on DailyMed (NIH) — the Drug Interactions and Use in Specific Populations sections of the Ozempic and Wegovy (semaglutide) labels and the Mounjaro and Zepbound (tirzepatide) labels — not an AI paraphrase or a third-party drug-monograph site. The contrast between the two drug classes is also supported by a peer-reviewed review of how GLP-1 medicines affect oral hormonal contraception. The general rule about vomiting and the pill (treat a vomit within roughly two to three hours of a dose as a missed pill) is standard contraceptive guidance, not a semaglutide-specific instruction. Labels are updated periodically, so always follow your current package insert and your prescriber. This is general information, not medical advice — your prescriber individualizes your care.

Does Ozempic make birth control less effective?

Based on the current labeling, no — semaglutide is not expected to reduce the effectiveness of oral contraceptives. The Ozempic and Wegovy (both semaglutide) prescribing information does not carry the kind of warning that tells patients on combined oral contraceptives to use a backup method or switch to a non-oral form.[1][2] A dedicated drug-interaction study and the broader clinical experience summarized in the label did not find that semaglutide meaningfully lowers oral-contraceptive exposure, which is why no such precaution appears.[1]

This is reinforced outside the label, too. A peer-reviewed review evaluating GLP-1 medicines and oral hormonal contraception reported that the GLP-1 receptor agonists it examined — the class semaglutide belongs to — did not produce a statistically or clinically meaningful reduction in oral-contraceptive blood levels, whereas tirzepatide did.[5] The mechanistic reason is gastric emptying: GLP-1 medicines slow how fast the stomach empties, which can in theory delay absorption of an oral pill, but for semaglutide this effect is modest and attenuates over time with continued dosing, and it has not translated into a labeled contraceptive warning.[5] In other words, the theoretical concern exists for the whole class, but the evidence and the label single out tirzepatide, not semaglutide.

Why Mounjaro (tirzepatide) is the real exception

Here is the contrast that trips people up: Mounjaro and Zepbound are tirzepatide, not semaglutide, and their labels carry an explicit contraceptive warning that the semaglutide labels do not. Tirzepatide is a dual GIP/GLP-1 receptor agonist, and it delays gastric emptying more strongly than the GLP-1-only drugs — most powerfully after the first dose and each dose increase — which can slow the absorption of an oral pill enough to lower its blood levels.[3][5]

Because of that, the tirzepatide prescribing information advises that oral hormonal contraceptives may be less effective and recommends that patients using them either switch to a non-oral contraceptive method (such as an IUD, implant, injection, patch, or vaginal ring) or add a barrier method for a defined window — for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase.[3][4] A pharmacology review confirmed the difference is real: tirzepatide measurably reduced the area-under-the-curve exposure of an oral contraceptive, while the GLP-1 receptor agonists it reviewed did not.[5] So if you are on Mounjaro or Zepbound rather than Ozempic or Wegovy, this warning applies to you and is worth taking seriously — see our Mounjaro drug page for more.

Semaglutide versus tirzepatide and oral birth control — what each FDA label says. Verified against the DailyMed (NIH) Ozempic, Wegovy, Mounjaro, and Zepbound prescribing information. This is general information; follow your current label and prescriber.
Semaglutide (Ozempic, Wegovy)Tirzepatide (Mounjaro, Zepbound)
Labeled oral-contraceptive warning?No — no warning that the pill may be less effectiveYes — label states oral contraceptives may be less effective
Backup or non-oral method advised?Not required by the label for the medication itselfYes — switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase
MechanismSlows gastric emptying modestly; effect attenuates over timeDual GIP/GLP-1 agonist delays gastric emptying more strongly, especially after the first dose
Practical caution that still appliesVomiting or diarrhea can reduce pill absorption; pregnancy must be avoidedSame GI and pregnancy cautions, plus the labeled contraceptive warning above

The two cautions that still apply on Ozempic

Even though semaglutide itself is not expected to weaken the pill, two practical issues mean contraception still deserves attention while you are on Ozempic or Wegovy.

1. Vomiting and diarrhea can reduce pill absorption

Nausea, vomiting, and diarrhea are among the most common semaglutide side effects, especially in the first weeks and after a dose increase.[1] An oral contraceptive only works if you actually absorb it — so a bout of significant vomiting or diarrhea can lower the amount of pill that reaches your bloodstream. Standard contraceptive guidance (not specific to semaglutide) is that if you vomit within roughly two to three hours of taking your pill, you should treat that as a missed dose and follow the missed-pill instructions for your specific product; severe or prolonged diarrhea is handled the same way.

  • If you vomit within about 2 to 3 hours of taking an oral contraceptive, follow your pill's missed-dose instructions and consider a backup method (such as condoms) until you are back on track.
  • If you have severe or prolonged diarrhea, treat it like a missed dose for that pill window, and use a backup method until things settle.
  • If GI side effects are frequent or severe, talk to your prescriber — a slower dose titration may reduce them, or a non-oral contraceptive (IUD, implant, injection, patch, or ring) sidesteps the absorption problem entirely because it does not rely on your gut.
  • Always read the missed-pill section of your contraceptive's package insert — instructions differ between combined and progestin-only pills.

2. Pregnancy must be avoided on semaglutide

This is the reason reliable contraception matters so much on Ozempic: semaglutide should not be used during pregnancy. Animal reproduction studies showed evidence of fetal harm, and the label advises against use in pregnancy and recommends discontinuing semaglutide at least 2 months before a planned pregnancy because of its long half-life — it takes time to clear from the body after the last dose.[1][2] So the goal while you are on semaglutide for weight or glucose management is to prevent pregnancy reliably, then plan a deliberate washout before trying to conceive.

Planning a pregnancy

If you want to become pregnant, talk to your prescriber before stopping contraception. The semaglutide labels advise stopping the medicine at least 2 months before a planned pregnancy because of its long half-life, and they advise against use during pregnancy based on animal data showing fetal harm. Do not stop your birth control until you and your clinician have a plan for the washout. If you think you may already be pregnant while on semaglutide, contact your prescriber promptly.[1][2]

What to do — practical, prescriber-directed steps

Whether you are on semaglutide or tirzepatide, the safe move is to make contraception a planned part of your treatment rather than an afterthought. The steps below are general and prescriber-directed — do not change your medication or your birth control on your own.

  • Tell your prescriber what contraception you use. This should be part of starting any GLP-1 or GIP/GLP-1 medicine, so they can flag the tirzepatide oral-contraceptive interaction or any other concern up front.
  • On tirzepatide (Mounjaro, Zepbound): if you use the oral pill, follow the label — add a barrier method or switch to a non-oral method for 4 weeks after starting and after each dose increase.[3][4]
  • On semaglutide (Ozempic, Wegovy) with severe GI side effects: consider asking about a non-oral method (IUD, implant, injection, patch, or ring), which does not depend on gut absorption and removes the vomiting-and-diarrhea worry.
  • Do not stop your birth control to "be safe" — that increases pregnancy risk, which is the very thing to avoid on these medicines. The goal is reliable contraception, not no contraception.
  • Plan the washout before pregnancy. Stop semaglutide at least 2 months before trying to conceive, on your prescriber's schedule, and keep using contraception until then.[1]
  • Read your pill's missed-dose instructions so you know exactly what to do after vomiting or diarrhea, and keep a backup method on hand.

If you are choosing where to start or continue semaglutide under proper supervision, compare the best semaglutide providers, or read our reviews of Found and Ro. A legitimate provider takes a full medication and contraception history, titrates you on the label schedule, and counsels you on pregnancy prevention — exactly the oversight that keeps treatment safe. For the full side-effect picture, see Ozempic side effects.

Frequently Asked Questions

Based on its current FDA labeling, no. Semaglutide (Ozempic, Wegovy) does not carry a warning that oral contraceptives may be less effective, and it has not been shown to meaningfully lower oral-contraceptive blood levels. This is different from tirzepatide (Mounjaro, Zepbound), whose label does carry such a warning. The practical exceptions for semaglutide are indirect: if gastrointestinal side effects make you vomit or have significant diarrhea, you may not fully absorb an oral pill, so standard missed-dose rules apply. Always confirm with your prescriber and follow your contraceptive's package insert.
Mounjaro (and Zepbound) is tirzepatide, and its label does warn that oral hormonal contraceptives may be less effective. Tirzepatide is a dual GIP/GLP-1 agonist that delays gastric emptying more strongly than GLP-1-only drugs, especially after the first dose and after each dose increase, which can reduce how much of an oral pill you absorb. The label advises switching to a non-oral contraceptive (such as an IUD, implant, injection, patch, or ring) or adding a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after each dose increase. If you are on Mounjaro or Zepbound and use the pill, talk to your prescriber about this.
Both classes slow gastric emptying, which can in theory delay the absorption of an oral pill. But tirzepatide, a dual GIP/GLP-1 receptor agonist, slows the stomach more powerfully, particularly after the first dose, and a peer-reviewed review found it measurably reduced oral-contraceptive exposure. The GLP-1 receptor agonists in that review, including semaglutide, did not show a statistically or clinically meaningful reduction, and semaglutide's gastric-emptying effect tends to attenuate over time. That is why the tirzepatide labels carry an oral-contraceptive warning and the semaglutide labels do not.
Pregnancy should be avoided while taking semaglutide. Animal studies showed evidence of fetal harm, and the label advises against use during pregnancy. Because semaglutide has a long half-life, the label also advises stopping it at least 2 months before a planned pregnancy so it can clear from your body. So reliable contraception is important on Ozempic precisely because pregnancy should be prevented. If you want to conceive, talk to your prescriber first and plan the washout before stopping birth control. If you think you may already be pregnant, contact your prescriber promptly.
For semaglutide itself, the label does not require a backup method the way the tirzepatide label does. However, a backup method is sensible during any episode of significant vomiting or diarrhea, since those can reduce pill absorption: if you vomit within roughly two to three hours of your pill, treat it as a missed dose. If you have frequent or severe GI side effects, ask your prescriber about a non-oral method (IUD, implant, injection, patch, or ring), which does not depend on gut absorption. Do not stop your birth control without a plan, because preventing pregnancy is the priority on these medicines.
Follow the missed-dose instructions for your specific contraceptive. The general rule is that if you vomit within about two to three hours of taking an oral contraceptive, you should treat it as a missed pill and use a backup method, such as condoms, until you are back on schedule. Severe or prolonged diarrhea is handled the same way. Because instructions differ between combined and progestin-only pills, read your product's package insert, and if vomiting or diarrhea is frequent, talk to your prescriber about easing the dose titration or moving to a non-oral contraceptive.

References

  1. 1.Novo Nordisk Inc. OZEMPIC (semaglutide) injection, for subcutaneous use — US Prescribing Information, §7 Drug Interactions (no warning that oral contraceptives are less effective), §8.1 Pregnancy, and §8.3 Females and Males of Reproductive Potential (discontinue at least 2 months before a planned pregnancy due to the long half-life). DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
  2. 2.Novo Nordisk Inc. WEGOVY (semaglutide) injection, for subcutaneous use — US Prescribing Information, §7 Drug Interactions and §8 Use in Specific Populations (pregnancy avoidance and pre-conception discontinuation guidance for semaglutide). DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  3. 3.Eli Lilly and Company MOUNJARO (tirzepatide) injection, for subcutaneous use — US Prescribing Information, §7 Drug Interactions (oral hormonal contraceptives may be less effective; advise a non-oral method or a barrier method for 4 weeks after initiation and after each dose escalation). DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
  4. 4.Eli Lilly and Company ZEPBOUND (tirzepatide) injection, for subcutaneous use — US Prescribing Information, §7 Drug Interactions, carrying the same oral-contraceptive precaution and backup-method window as the Mounjaro label. DailyMed (NIH). 2025. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  5. 5.Skelley JW, Swearengin K, York AL, Glover LH The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception. Journal of the American Pharmacists Association. 2024. PMID: 37940101.

Wegovy and Birth Control: Does Semaglutide Affect the Pill?

Wegovy carries no labeled warning that birth control is less effective, unlike Mounjaro/Zepbound (tirzepatide) — the FDA label, the drug-interaction data, and the two real cautions that still apply.

9 min read

Zepbound and Birth Control: Does Tirzepatide Make the Pill Less Effective?

Zepbound's FDA label warns that the pill may be less effective on tirzepatide — the exact §7.2/§8.3 language, why Wegovy carries no equivalent warning, and the 4-week backup-contraception window.

9 min read

What Birth Control Causes Weight Loss? An Evidence Review of Hormonal Contraception and Body Weight (2026)

Almost no clinical evidence supports weight LOSS with hormonal contraception. The Cochrane systematic review of progestin-only contraceptives (Lopez 2016, PMID 27567593) and the Cochrane review of combination contraceptives (Gallo 2014, PMID 24477630) both concluded the available evidence does not establish a causal effect on weight, with most studies showing weight-neutral outcomes. Some progestin-only formulations — particularly depot medroxyprogesterone (Depo-Provera) — are associated with weight GAIN (Dianat 2019, PMID 30633132). Hormonal IUDs (Mirena, Kyleena) show weight changes similar to copper IUDs (Dal'Ava 2012, PMID 22445431). The 'birth control that causes weight loss' search demand reflects a real patient question, but the honest evidence answer is: no FDA-approved hormonal contraceptive reliably causes meaningful weight loss. This article documents what the evidence actually says and points readers to the primary-source-anchored options that DO produce weight loss.

11 min read

Mounjaro and Birth Control: Why Tirzepatide Can Make the Pill Less Effective (2026)

Mounjaro (tirzepatide) carries an explicit FDA-label warning that oral birth control may be less effective because it delays gastric emptying. The 4-week backup-contraception windows, why this differs from semaglutide, and what to do — verified against the DailyMed Mounjaro and Zepbound labels.

8 min read

Wegovy and Pregnancy: Is Semaglutide Safe? The 2-Month Washout Rule

The current FDA Wegovy label: discontinue once pregnancy is recognized, stop at least 2 months before trying to conceive, and the injection-vs-tablet breastfeeding distinction most people miss.

13 min read

Tirzepatide and Sex Drive in Women: What the Mounjaro and Zepbound Evidence Shows

No trial measures tirzepatide on female libido. Honest evidence on Mounjaro/Zepbound, weight loss and women's sexual function, PCOS, side effects and birth control.

11 min read